rs5987173

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001278116.2(L1CAM):​c.2307C>T​(p.Ser769Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00318 in 1,209,155 control chromosomes in the GnomAD database, including 65 homozygotes. There are 1,075 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 33 hom., 487 hem., cov: 23)
Exomes 𝑓: 0.0019 ( 32 hom. 588 hem. )

Consequence

L1CAM
NM_001278116.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.542
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.026).
BP6
Variant X-153866773-G-A is Benign according to our data. Variant chrX-153866773-G-A is described in ClinVar as [Benign]. Clinvar id is 92925.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153866773-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.542 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0527 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L1CAMNM_001278116.2 linkc.2307C>T p.Ser769Ser synonymous_variant Exon 19 of 29 ENST00000370060.7 NP_001265045.1 P32004-1
L1CAMNM_000425.5 linkc.2307C>T p.Ser769Ser synonymous_variant Exon 18 of 28 NP_000416.1 P32004-1
L1CAMNM_024003.3 linkc.2307C>T p.Ser769Ser synonymous_variant Exon 18 of 27 NP_076493.1 P32004-2
L1CAMNM_001143963.2 linkc.2292C>T p.Ser764Ser synonymous_variant Exon 17 of 26 NP_001137435.1 P32004-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L1CAMENST00000370060.7 linkc.2307C>T p.Ser769Ser synonymous_variant Exon 19 of 29 5 NM_001278116.2 ENSP00000359077.1 P32004-1

Frequencies

GnomAD3 genomes
AF:
0.0158
AC:
1766
AN:
111669
Hom.:
33
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0548
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00577
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000207
Gnomad OTH
AF:
0.00933
GnomAD2 exomes
AF:
0.00475
AC:
871
AN:
183239
AF XY:
0.00332
show subpopulations
Gnomad AFR exome
AF:
0.0577
Gnomad AMR exome
AF:
0.00321
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000122
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00189
AC:
2072
AN:
1097434
Hom.:
32
Cov.:
31
AF XY:
0.00162
AC XY:
588
AN XY:
362820
show subpopulations
Gnomad4 AFR exome
AF:
0.0638
AC:
1684
AN:
26385
Gnomad4 AMR exome
AF:
0.00352
AC:
124
AN:
35205
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
19381
Gnomad4 EAS exome
AF:
0.0000331
AC:
1
AN:
30205
Gnomad4 SAS exome
AF:
0.000203
AC:
11
AN:
54136
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
40495
Gnomad4 NFE exome
AF:
0.0000963
AC:
81
AN:
841421
Gnomad4 Remaining exome
AF:
0.00367
AC:
169
AN:
46073
Heterozygous variant carriers
0
94
189
283
378
472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0159
AC:
1771
AN:
111721
Hom.:
33
Cov.:
23
AF XY:
0.0144
AC XY:
487
AN XY:
33925
show subpopulations
Gnomad4 AFR
AF:
0.0549
AC:
0.0548788
AN:
0.0548788
Gnomad4 AMR
AF:
0.00576
AC:
0.00576451
AN:
0.00576451
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.000207
AC:
0.000207289
AN:
0.000207289
Gnomad4 OTH
AF:
0.00922
AC:
0.00921659
AN:
0.00921659
Heterozygous variant carriers
0
65
130
195
260
325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0147
Hom.:
55
Bravo
AF:
0.0182
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Aug 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 12, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spastic paraplegia Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 26, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hereditary spastic paraplegia Benign:1
May 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
5.8
DANN
Benign
0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5987173; hg19: chrX-153132228; COSMIC: COSV100648974; COSMIC: COSV100648974; API